Dr. Maniar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
1 Maloney Building
Philadelphia, PA 19104Phone+1 215-662-3681
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010- University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
CA State Medical License 2011 - 2018
PA State Medical License 2006 - 2014
Clinical Trials
Publications & Presentations
PubMed
- 863 citationsSafety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.Max S. Topp, Nicola Gökbuget, Anthony S. Stein, Gerhard Zugmaier, Susan O'Brien
The Lancet. Oncology. 2015-01-01 - 34 citationsUnleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapyZachary Zimmerman, Tapan Maniar, Dirk Nagorsen
International Immunology. 2015-01-01 - 4 citationsChildhood ALL and second neoplasms.Tapan Maniar, Inbal Braunstein, Stephen M. Keefe, Sofia Hussen, Tara Abrams
Cancer Biology & Therapy. 2007-10-01
Press Mentions
Cherry Thomas Joins Caribou as SVP of Clinical Development; Artax Locks in Joseph Lobacki as CEOMay 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
